Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.170
-0.060 (-2.69%)
At close: Mar 18, 2026, 4:00 PM EDT
2.140
-0.030 (-1.38%)
After-hours: Mar 18, 2026, 4:30 PM EDT
BDTX Stock Forecast
Stock Price Forecast
The 5 analysts that cover BDTX stock have a consensus rating of "Buy" and an average price target of $10.2, which forecasts a 370.05% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $14.
Price Target: $10.2 (+370.05%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BDTX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 2 |
| Buy | 1 | 2 | 2 | 2 | 2 | 3 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +545.16% | Mar 17, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +268.66% | Jan 16, 2026 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $9 | Buy | Initiates | $9 | +314.75% | Nov 18, 2025 |
| Stifel | Stifel | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +268.66% | Oct 16, 2025 |
Financial Forecast
Revenue This Year
n/a
from 70.00M
Revenue Next Year
n/a
EPS This Year
-0.64
from 0.39
EPS Next Year
-1.00
from -0.64
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.20 | -0.53 | |||
| Avg | -0.64 | -1.00 | |||
| Low | -0.88 | -1.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.